Detalhe da pesquisa
1.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
2.
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Eur Respir J
; 62(5)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827576
3.
Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18.
Monaldi Arch Chest Dis
; 91(1)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470081
4.
Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19.
Monaldi Arch Chest Dis
; 91(1)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470080
5.
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
Am J Respir Crit Care Med
; 198(3): 379-386, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509468
6.
Multidrug-resistant tuberculosis in Europe, 2010-2011.
Emerg Infect Dis
; 21(3): 409-16, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25693485
7.
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
N Engl J Med
; 375(11): 1103-5, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626539
8.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Lancet Respir Med
; 12(2): 117-128, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980911
9.
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
Eur Respir J
; 49(6)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596434
10.
Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus: Mixed-Methods Study.
Int J Environ Res Public Health
; 19(7)2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410048
11.
Safety of prolonged treatment with bedaquiline in programmatic conditions.
ERJ Open Res
; 8(2)2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35586446
12.
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.
Int J Mycobacteriol
; 5 Suppl 1: S23, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28043573
13.
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.
J Clin Tuberc Other Mycobact Dis
; 4: 21-27, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27284577